RYCORZ

Serial Number 87642735
606

Registration Progress

Application Filed
Oct 12, 2017
Under Examination
Mar 13, 2018
Approved for Publication
Jan 16, 2018
Published for Opposition
Jan 16, 2018
Registered

Trademark Image

RYCORZ

Basic Information

Serial Number
87642735
Filing Date
October 12, 2017
Published for Opposition
January 16, 2018
Abandonment Date
April 19, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 19, 2021
Classes
005

Rights Holder

Actelion Pharmaceuticals Ltd

99
Address
Gewerbestrasse 16
Allschwil 4123
CH

Ownership History

Actelion Pharmaceuticals Ltd

Original Applicant
99
Allschwil CH

Actelion Pharmaceuticals Ltd

Owner at Publication
99
Allschwil CH

Legal Representation

Attorney
Cheryl Foytlin

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Apr 19, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 19, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 23, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 22, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 22, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 14, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 14, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 14, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 12, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 12, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 12, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 17, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 13, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 13, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 13, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 2, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 28, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 28, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 28, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 7, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 5, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 5, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 5, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 13, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 6, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 6, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 16, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 16, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 27, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 4, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 24, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 20, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 16, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005